Roy Vergis
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 4
- Prostate Cancer Diagnosis and Treatment 1
- Oncology 3
- Colorectal Cancer Treatments and Studies 1
- Cytokine Signaling Pathways and Interactions 1
- Cancer-related Molecular Pathways 1
- Co-authors
- Chris Parker (4 shared papers)Robert Huddart (3 shared papers)Catherine M. Corbishley (2 shared papers)Alan Horwich (2 shared papers)Rosalind A. Eeles (2 shared papers)Matthew R. Sydes (2 shared papers)Vincent Khoo (2 shared papers)David P. Dearnaley (3 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Journal of Clinical Pathology (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Modern Pathology (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United KingdomDenmark
In The Last Decade
Roy Vergis
5 papers receiving 298 citations
Peers
Comparison fields: 5 of 47
- Cancer Research 166
- Pulmonary and Respiratory Medicine 178
- Hepatology 15
- Oncology 51
- Radiology, Nuclear Medicine and Imaging 43
Countries citing papers authored by Roy Vergis
This map shows the geographic impact of Roy Vergis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Vergis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Vergis more than expected).
Fields of papers citing papers by Roy Vergis
This network shows the impact of papers produced by Roy Vergis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Vergis. The network helps show where Roy Vergis may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy Vergis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 229 | |
| 2 | 2012 | 35 | |
| 3 | 2010 | 25 | |
| 4 | 2009 | 9 | |
| 5 | 2017 | 2 | |
| 6 | 2009 | 0 |
About Roy Vergis
Roy Vergis is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 6 papers that have together received 300 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Prostate Cancer Diagnosis and Treatment (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper), Cancer-related Molecular Pathways (1 paper) and PI3K/AKT/mTOR signaling in cancer (1 paper). The work is most often cited by research in Cancer Research (166 citations), Pulmonary and Respiratory Medicine (178 citations), Hepatology (15 citations), Oncology (51 citations) and Radiology, Nuclear Medicine and Imaging (43 citations). Roy Vergis has collaborated with scholars based in United Kingdom and Denmark. Frequent co-authors include Chris Parker, Robert Huddart, Catherine M. Corbishley, Alan Horwich, Rosalind A. Eeles, Matthew R. Sydes, Vincent Khoo, David P. Dearnaley, Michael Borre and Sameer Jhavar. Their work appears in journals such as Journal of Clinical Oncology, Journal of Clinical Pathology, International Journal of Radiation Oncology*Biology*Physics, Modern Pathology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.